FDA recall,
American Regent BetaVet Betamethasone Injectable Suspension for Horses
BetaVet betamethasone injectable suspension has defective container seals.
Summary by Recall Canary from the FDA notice
What happened
American Regent Inc. recalled BetaVet betamethasone sodium phosphate and betamethasone acetate injectable suspension, 6 mg betamethasone/mL, For Intra-Articular Use in Horses, because of defective container loose or defective crimps or seals. The product is a single dose vial, 1 vial (5 mL), from American Regent, Inc., Animal Health, Shirley, NY 11967.
The recall began October 12, 2026, and was added to the FDA's Enforcement Report on October 19, 2026. The product was distributed nationwide within the U.S.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match the NDC and lot code listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
- NDC
- 10797-720-01
- Lot code
- 26038L2C1
Recall details
- Company began the recall
- Sold in
Nationwide within the U.S.
- Company
- American Regent Inc.
- Hazard
- Packaging defect
- Event ID
- 100094
All recalls from American Regent Inc.
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report
Listed on Recall Canary
